Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Boston Announces Canadian Approval, Launch Of PROMUS Element Plus Stent System

4/25/2012 8:54 AM ET

Boston Scientific Corp. (BSX: Quote) announced Health Canada approval and market launch of the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System in Canada.

According to the company, the new stent system incorporates the platinum chromium alloy and innovative stent design of the PROMUS Element Stent with an enhanced catheter delivery system engineered for improved performance in treating patients with coronary artery disease. The company noted that it plans to begin marketing the product immediately in Canada.

Click here to receive FREE breaking news email alerts for Boston Scientific Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.